Qipianadministration has both preventive and therapeutic effects on COPD possiblyby regulating the microbiota dysbiosis through the gut-lung axis, inhibitingthe activation of the TLR4/NF-κB pathway, reducing inflammation, andimproving lung function. Here, NFKB1 is linked to chronic obstructive pulmonary disease.